RSI Oversold Bounce Stocks · Biological Products, (No Diagnostic Substances)
5 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GLUE | Monte Rosa Therapeutics, Inc. | 0.10 | 1.12 | -3.17% | -24.91% | -22.31% | Golden | 38.49 | 40.3% | Bullish | Sell | -44.12% | +200.10% | -1.97% | Double Top | — | 14.39 | +1.12% |
| GRML | Greenland Mines Ltd | 2.07 | 1.40 | -45.33% | -55.29% | — | — | 30.12 | 0.4% | Bearish | Sell | -84.40% | +0.90% | +1.65% | — | — | 4.50 | -7.31% |
| SCLX | Scilex Holding Co | 0.39 | 0.37 | -11.61% | -24.75% | -43.05% | Death | 28.50 | 3.9% | Bearish | Sell | -84.51% | +2.31% | +0.28% | — | Inverted Hammer | 5.31 | -0.56% |
| PMCB | PharmaCyte Biotech, Inc. | 0.41 | 0.02 | -7.56% | -19.51% | -33.22% | Death | 31.60 | 20.6% | Bullish | Sell | -67.12% | +3.08% | +0.53% | — | — | 0.49 | +1.62% |
| VIVS | VivoSim Labs, INC. | 0.13 | 0.05 | -9.84% | -46.85% | -81.31% | Death | 30.25 | 10.5% | Bullish | Sell | -94.95% | +2.15% | -0.97% | — | Doji | 0.28 | -1.01% |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.
Cite this data: “RSI Oversold Bounce Stocks”, tradmap.com, data as of 2026-09-18 — tradmap.com/screener/rsi-oversold-bounce.
Free to cite with attribution and a link.